NOSU
NOTICE OF SUIT
07/16/2026
Back to search
Official data from USPTO
PHARMA DEVELOPPEMENT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHARMA DEVELOPPEMENT
ST13
US500000097640718Class
3, 35
Filing
97640718
Registration
7348565
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
07/16/2026
Trademark type
Word
Nice classes
3, 35
Filing date
10/20/2022
Registration date
04/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/02/2024
Last transaction
07/16/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2020-01-00
First use in commerce
2020-01-00
Drawing code
4
Owner type
03
Owner location
CORAL GABLES, FL, US
Examiner
AYALA, LOURDES
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
US HEALTH DRUGSTORE INC
US HEALTH DRUGSTORE LLC
Representatives
Eric P. Gros-Dubois EPGD ATTORNEYS AT LAW, P.A.
Technical classification
Nice Classes
Class 3Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Cosmetics
Class 35
On-line retail store services featuring a wide variety of consumer goods of others; On-line retail store services featuring dietary and nutritional supplementsfood supplementscosmetics and make-upperfumescreamshealth productsbeauty productsskincare products; Retail store services featuring dietary and nutritional supplementsfood supplementscosmetics and make-upperfumescreamshealth productsbeauty productsskincare products
Publications
History of USPTO decisions and trademark events.
22 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/02/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/02/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/29/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/28/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/24/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/24/2024
IUAF
USE AMENDMENT FILED
02/01/2024
EISU
TEAS STATEMENT OF USE RECEIVED
02/01/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/24/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/29/2023
PUBO
PUBLISHED FOR OPPOSITION
08/29/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/09/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/24/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
07/20/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/20/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
07/20/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/20/2023
DOCK
ASSIGNED TO EXAMINER
07/12/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/15/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/04/2022
NWAP
NEW APPLICATION ENTERED
10/24/2022
Continuous trademark protection
Get notified about every new filing that threatens PHARMA DEVELOPPEMENT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.